Cost of PreP since funding began in 2018

Elliot Ikilei made this Official Information request to Pharmaceutical Management Agency

The request was successful.

From: Elliot Ikilei

Dear Pharmaceutical Management Agency,

Please provide a monetary value of the cost spent funding Truvada, otherwise known as PrEP, for the period from 1 January 2018 up to and including 31 December 2020, or as close to this date as possible, including partial funding.

Yours faithfully,

Elliot Ikilei

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

“Kia ora,

 

Thank you for emailing PHARMAC enquiries. We will be closed over the
holiday period from 1PM 24 December and will reopen on 5 January 2021.

 

Ngâ mihi,

 

PHARMAC Enquiries”

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Kia ora Elliot

 

Thank you for your request for information under the Official Information
Act 1982, dated 6 January 2021.

 

Your request has been received and logged. As required under the OIA, we
will respond to your request within 20 working days. You should receive a
response on or before 15 February 2021 (please note, this response date
takes into account working days as defined in the Act).

 

If a large amount of information has been requested, we may need to extend
the due date (this is provided for in section 15A of the Act). We will
advise you if such an extension is necessary.

 

Our reference number for your request is: 2020-21-077.

 

Ngā mihi

 

 

Melody Willis ([1]she/her) | Government Services Adviser

___________________________________________________________________

PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington

P: +64 4 460 4990 |[2]www.pharmac.govt.nz

 

-----Original Message-----
From: Elliot Ikilei <[FOI #14402 email]>
Sent: Wednesday, 6 January 2021 2:56 am
To: Web Enquiry <[email address]>
Subject: Official Information request - Cost of PreP since funding began
in 2018

 

Dear Pharmaceutical Management Agency,

 

Please provide a monetary value of the cost spent funding Truvada,
otherwise known as PrEP, for the period from 1 January 2018 up to and
including 31 December 2020, or as close to this date as possible,
including partial funding.

 

Yours faithfully,

 

Elliot Ikilei

 

-------------------------------------------------------------------

 

This is an Official Information request made via the FYI website.

 

Please use this email address for all replies to this request:

[3][FOI #14402 email]

 

Is [4][PHARMAC request email] the wrong address for Official Information
requests to Pharmaceutical Management Agency? If so, please contact us
using this form:

[5]https://fyi.org.nz/change_request/new?bo...

 

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[6]https://fyi.org.nz/help/officers

 

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

 

 

-------------------------------------------------------------------

 

References

Visible links
1. https://www.publicservice.govt.nz/our-wo...
2. file:///tmp/www.pharmac.govt.nz
3. mailto:[FOI #14402 email]
4. mailto:[PHARMAC request email]
5. https://fyi.org.nz/change_request/new?bo...
6. https://fyi.org.nz/help/officers

hide quoted sections

Link to this

From: Elliot Ikilei

Dear Web Enquiry,

Please note the lateness of your reply; I request that my OIA is honoured

Yours sincerely,

Elliot Ikilei

Link to this

From: Web Enquiry
Pharmaceutical Management Agency

Thank you for emailing PHARMAC enquiries.

View a list of all currently funded medicines (the Pharmaceutical
Schedule)

View the progress of funding applications on the Application Tracker

Read our latest COVID-19 updates

We will endeavour to get back to you within five working days.

Ngā mihi,

PHARMAC Enquiries
___________________________________________________________________
PHARMAC | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington
P: 0800 660 050 | www.pharmac.govt.nz

Link to this

From: Web Enquiry
Pharmaceutical Management Agency


Attachment 2020 21 077 2021 02 05 response letter cost spent funding emtricitabine with tenofovir disoproxil.pdf
114K Download View as HTML


Kia ora Elliot

 

Please find attached a response to your request for information received
by PHARMAC on 6 January 2021.

 

Please feel free to contact us if you require any further assistance.

 

Ngā mihi

 

 

Melody Willis ([1]she/her) | Government Services Adviser

___________________________________________________________________

PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington

P: +64 4 460 4990 |[2]www.pharmac.govt.nz

 

From: Web Enquiry
Sent: Wednesday, 6 January 2021 10:03 am
To: 'Elliot Ikilei' <[3][FYI request #14402 email]>
Subject: OIA 2020-21-077 acknowledgement - cost of funding PrEP

 

Kia ora Elliot

 

Thank you for your request for information under the Official Information
Act 1982, dated 6 January 2021.

 

Your request has been received and logged. As required under the OIA, we
will respond to your request within 20 working days. You should receive a
response on or before 15 February 2021 (please note, this response date
takes into account working days as defined in the Act).

 

If a large amount of information has been requested, we may need to extend
the due date (this is provided for in section 15A of the Act). We will
advise you if such an extension is necessary.

 

Our reference number for your request is: 2020-21-077.

 

Ngā mihi

 

 

Melody Willis ([4]she/her) | Government Services Adviser

___________________________________________________________________

PHARMAC | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer
Street, Wellington

P: +64 4 460 4990 |[5]www.pharmac.govt.nz

 

-----Original Message-----
From: Elliot Ikilei <[6][FYI request #14402 email]>
Sent: Wednesday, 6 January 2021 2:56 am
To: Web Enquiry <[7][email address]>
Subject: Official Information request - Cost of PreP since funding began
in 2018

 

Dear Pharmaceutical Management Agency,

 

Please provide a monetary value of the cost spent funding Truvada,
otherwise known as PrEP, for the period from 1 January 2018 up to and
including 31 December 2020, or as close to this date as possible,
including partial funding.

 

Yours faithfully,

 

Elliot Ikilei

 

-------------------------------------------------------------------

 

This is an Official Information request made via the FYI website.

 

Please use this email address for all replies to this request:

[8][FYI request #14402 email]

 

Is [9][PHARMAC request email] the wrong address for Official Information
requests to Pharmaceutical Management Agency? If so, please contact us
using this form:

[10]https://fyi.org.nz/change_request/new?bo...

 

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:

[11]https://fyi.org.nz/help/officers

 

If you find this service useful as an Official Information officer, please
ask your web manager to link to us from your organisation's OIA or LGOIMA
page.

 

 

-------------------------------------------------------------------

 

 

References

Visible links
1. https://www.publicservice.govt.nz/our-wo...
2. file:///tmp/www.pharmac.govt.nz
3. mailto:[FYI request #14402 email]
4. https://www.publicservice.govt.nz/our-wo...
5. file:///tmp/www.pharmac.govt.nz
6. mailto:[FYI request #14402 email]
7. mailto:[PHARMAC request email]
8. mailto:[FYI request #14402 email]
9. mailto:[PHARMAC request email]
10. https://fyi.org.nz/change_request/new?bo...
11. https://fyi.org.nz/help/officers

hide quoted sections

Link to this

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: